Yan Li
Celgene
1 Papers
1 Citations
Yan Li is an academic researcher from Celgene. The author has contributed to research in topics: Physiologically based pharmacokinetic modelling. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Assessment of drug-drug interaction potential and PBPK modeling of CC-223, a potent inhibitor of the mammalian target of rapamycin kinase.
Zeen Tong,Rangaraj Narayanan,Christian Atsriku,Jim Nissel,Yan Li,Hong Liu,Xiaomin Wang,Sekhar Surapaneni +7 more
TL;DR: Model based predictions of DDI with ketoconazole were in agreement with observed results enabling prospective predictions of DDIs between CC-223 and CYP3A4 inhibitors, and PBPK model of CC- 223 and M1 was developed and verified using clinical results.
1